Carlsmed, Inc. (CARL) vs National Research Corporation (NRC)
- Carlsmed, Inc. CARL 13.41 −3.87%
- National Research Corporation NRC 20.15 −4.55%
Carlsmed, Inc. and National Research Corporation are both Health Information Services companies. National Research Corporation is the larger, with a market value of $466.9M against $380.9M — 1.2× the size. Carlsmed, Inc. has negative trailing earnings, so its P/E is not meaningful; National Research Corporation trades at 80.6×. Carlsmed, Inc. grew revenue faster over the last twelve months: 81.1% against −0.23%. National Research Corporation has the higher net margin (3.96% vs −57.4%) and the higher return on invested capital (10.3% vs −234.5%). Across the 17 metrics below, National Research Corporation leads on 11 and Carlsmed, Inc. on 6.
Valuation
Profitability
| Metric | CARL | NRC | Health Information Services median |
|---|---|---|---|
| Gross margin | 76.63% | 61.75% | 62.87% |
| Operating margin | (61.09%) | 10.53% | (9.45%) |
| Net margin | (57.42%) | 3.96% | (15.48%) |
| Free cash flow margin | (56.36%) | 15.46% | 0.00% |
| Return on equity | (6,196.93%) | 39.82% | (6.91%) |
| Return on assets | (42.39%) | 4.00% | (6.28%) |
| Return on invested capital | (234.53%) | 10.32% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack